BETSY NULL: Open Payments
NPI 1154445849 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 54 payments from 17 companies in 2025. Trend: 2023 $1,218 · 2024 $1,406 · 2025 $986
Food & beverage: $986
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $172 |
| GlaxoSmithKline, LLC. | 10 | $159 |
| Lilly USA, LLC | 8 | $147 |
| Novo Nordisk Inc | 6 | $101 |
| PFIZER INC. | 5 | $98 |
| Amgen Inc. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Astellas Pharma US Inc | 2 | $28 |
Products named: FREESTYLE LIBRE 3, TRELEGY ELLIPTA, JARDIANCE, MOUNJARO, Ozempic, ELIQUIS, Wegovy, SHINGRIX.
Industry payments across TX — which companies pay providers there.
